Global Catheter-Related Bloodstream Infection Market
HealthcareServices

Catheter-Related Bloodstream Infection Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the catheter-related bloodstream infection market grown over the years?

The catheter-related bloodstream infection market has experienced strong growth in recent years. It is expected to increase from $1.53 billion in 2024 to $1.62 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.2%. The historical growth can be attributed to the rising incidence of chronic diseases, greater awareness and education about infections, the growing elderly population, and improved infection control programs in healthcare facilities.

What Is the forecasted market size and growth rate for the catheter-related bloodstream infection market?

The catheter-related bloodstream infection market is anticipated to reach $2.05 billion by 2029, growing at a CAGR of 6.0%. This growth is attributed to the rising healthcare-associated infections (HAIs), better awareness and training, improved infection control practices, expanding healthcare infrastructure, and government initiatives. Trends include biomaterial innovations, smart catheter technology, advanced antimicrobial catheter lock solutions, improvements in sterilization processes, and automated flushing systems.

Get your catheter-related bloodstream infection market report here!

https://www.thebusinessresearchcompany.com/report/catheter-related-bloodstream-infection-global-market-report

What are the major factors driving growth in the catheter-related bloodstream infection market?

The growth of the catheter-related bloodstream infection market is expected to be driven by the rising prevalence of hospital-acquired infections (HAIs). HAIs occur when patients acquire infections during treatment for other conditions, typically manifesting 48 hours or more after admission. Factors such as antimicrobial resistance, insufficient infection control, and patient susceptibility contribute to their increase. Catheter-related bloodstream infections are significant due to their invasive nature and microbial colonization risk. For example, in January 2023, the National Library of Medicine reported a global HAI rate of 0.14%, rising annually by 0.06%. This surge in HAIs will contribute to the market’s growth.

What key areas define the segmentation of the global catheter-related bloodstream infection Market?

The catheter-related bloodstream infection market covered in this report is segmented –

1) By Treatment: Antibiotic Lock Therapy, Anti-Microbial Agents

2) By Source Of Infection Or Causative Agents: Staphylococcus Aureus, Acinetobacter Baumannii, Escherichia Coli (E. Coli), Klebsiella Pneumoniae (K. Pneumonia), Candida Species (Candida Sp.), Pseudomonas Aeruginosa (P. Aeruginosa), Other Source Of Infection Or Causative Agents

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Antibiotic Lock Therapy: Catheter Lock Solutions (Antibiotic-based), Combination Antibiotic Lock Therapy

2) By Anti-Microbial Agents: Antibiotics, Antifungal Agents, Antiseptic Agents

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16646&type=smp

What are the top market players propelling the growth of the catheter-related bloodstream infection industry?

Major companies operating in the catheter-related bloodstream infection market are Pfizer Inc., Johnson & Johnson Services Inc., Novartis AG, 3M Company, Eli Lilly and Company, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company, Viatris Inc., B. Braun Medical Inc., Aurobindo Pharma Limited, Lupin Ltd., Xellia Pharmaceuticals Ltd., SteriMax Inc., Geistlich Pharma AG, Bactiguard AB, Hetero Healthcare Ltd., TauroPharm GmbH, Advacare Pharma, Citus Pharmaceuticals Inc., CorMedix Inc., JoinHub Pharma LLP, IntegraDose Compounding Services LLC

What are the key trends shaping the future of the catheter-related bloodstream infection market?

In the catheter-related bloodstream infection market, businesses are developing catheter lock solutions to enhance infection prevention. For example, in November 2023, CorMedix Inc., a US-based biopharmaceutical company, received FDA approval for the DefenCath catheter lock solution, combining antimicrobial properties and anticoagulation to prevent catheter-related infections in patients undergoing chronic hemodialysis.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16646

What regions are dominating the catheter-related bloodstream infection market growth?

North America was the largest region in the catheter-related bloodstream infection market in 2023. The regions covered in the catheter-related bloodstream infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

PTA Balloon Catheter Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pta-balloon-catheter-global-market-report

Intravascular Catheters Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/intravascular-catheters-global-market-report

Intermittent Catheters Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/intermittent-catheters-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: